Kashiv Pharma Revenue and Competitors

Kashiv scientists maintain two key focus points. The first is developing and applying novel technologies to improve the delivery of compounds with otherwise problematic physical and/or chemical properties. The Kashiv portfolio of proprietary drug delivery technologies is designed to improve the efficacy, safety, compliance, and dosage of low-bioavailability drugs where absorption could be limited due to solubility, permeability, and/or stability problems. The second area of focus is developing the next generation of improved, abuse-deterrent formulations (ADF) in the hopes of curbing prescription drug abuse. The comprehensive Kashiv ADF platforms target popularly abused drugs, such as opioids, and build in features to prevent common methods of abuse, misuse, and overdose of drugs.